research

Toyota Partners with Luminar on the Newest Version of Autonomous Platform

Toyota Partners with Luminar on the Newest Version of Autonomous Platform

On Wednesday, Toyota Research Institute, which is Toyota Motor Corp (NYSE: TM) research arm, announced that it would partner with Luminar on its newest version of autonomous platform.Luminar was founded five years ago, and began to develop a new LiD..

Twitter to Test 280 Characters Tweet

Twitter to Test 280 Characters Tweet

Twitter Inc (NYSE: TWTR) on Wednesday announced to expand the length of a tweet to 280 characters from 140 characters, a move that aims to attract more users.The social media company said in a blog post that the new feature will start with &ldq..

Ascendis Pharma Shares Jump While Competitor Misses Results

Ascendis Pharma Shares Jump While Competitor Misses Results

Ascendis Pharma A/S (NASDAQ: ASND) shares jumped over 40% in premarket on Friday following the news that its competitor, Versartis Inc. (NASDAQ: VSAR) late-stage clinical trial missed its primary endpoint. Versartis shares plummeted down over 86 per..

IBM invests $240 for AI research with MIT

IBM invests $240 for AI research with MIT

International Business Machines Corp. (NYSE: IBM) and Massachusetts Institute of Technology announced on Thursday that the two plan for 10 year, $240 million investment to create the MIT-IBM Watson AI Lab. The lab’s purpose is to research fund..

Merck Acquires Rigontec for $550 Million

Merck Acquires Rigontec for $550 Million

Merck & Co. Inc. (NYSE: MRK) announced today its acquisition of German biotech start-up, Rigontec for approximately €464 million or $550 million to further advance studies and research in cancer treatment development.Merck agreed to pay &eu..

U.S. Industrial Output Expected to Show Gains

U.S. Industrial Output Expected to Show Gains

Experts believe that the U.S. Industrial output numbers could give cause for celebration. The numbers are expected to show a gain. Preliminary numbers promise to make good these expectations.As far as industrial activity goes. the numbers have shown..

The FDA Scheduled to Review Novartis’ Gene Therapy Drug on Wednesday

The FDA Scheduled to Review Novartis’ Gene Therapy Drug on Wednesday

Novartis AG (NYSE: NVS) is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The U.S. Food and Drug Administration will ask a panel of advisers to focus on the safety of ..